Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer

Annals of Oncology

Volumn 25, Issue 6, 2014, Pages 1179-1184

  Hirabayashi, S ^a   Kosugi, Shin Ichi ^b   Isobe, Y ^c   Nashimoto, A ^d   Oda, I ^e   Hayashi, K ^f   Miyashiro, I ^g   Tsujitani, S ^h   Kodera, Y ⁱ   Seto, Y ^j   Furukawa, H ^k   Ono, H ^l   Tanabe, S ^m   Kaminishi, M ⁿ   Nunobe, S ^o   Fukagawa, T ^e   Matsuo, R ^a   Nagai, T ^a   Katai, H ^e   Wakai, T ^b   Akazawa, K ^a   more..

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^d NIIGATA CANCER CENTER HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f Yamagata Prefectural Kahoku Hospital   (Japan)

^g OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

^k KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l SHIZUOKA CANCER CENTER   (Japan)

^m KITASATO UNIVERSITY HOSPITAL   (Japan)

ⁿ Showa General Hospital   (Japan)

^o CANCER INSTITUTE HOSPITAL   (Japan)

more..

Author keywords

Advanced gastric cancer; External validation; Multivariable analysis; Nomogram; Prognosis; Survival analysis

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COMPUTER PROGRAM; FEMALE; HUMAN; JAPAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERODIAGNOSIS; SEX DIFFERENCE; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; VALIDATION STUDY; ADENOCARCINOMA; GASTRECTOMY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STOMACH NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NOMOGRAMS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84903905793     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu125     Document Type: Article

References (21)

1. International Agency for Research on Cancer, World Health Organization. Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. http://globocan.iarc.fr/(17 August 2013, date last accessed).
2. Vital Statistics Japan (Ministry of Health, Labour and Welfare). http://ganjoho.jp/professional/statistics/statistics.html (17 August 2013, date last accessed).
3. Son T, Hyung WJ, Lee JH et al. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer 2012; 118: 4687-4693.
4. Edge SB BD, Compton CC, Fritz AG et al. AJCC Cancer Staging Manual, 7th ed. New York: Springer 2010.
5. Zu H, Wang F, Ma Y et al. Stage-stratified analysis of prognostic significance of tumor size in patients with gastric cancer. PLoS One 2013; 8(1): e54502
6. Kunisaki C, Makino H, Kimura J et al. Impact of lymphovascular invasion in patients with stage I gastric cancer. Surgery 2010; 147: 204-211.
7. Li C, Oh SJ, Kim S et al. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology 2009; 77: 197-204.
8. Kunisaki C, Akiyama H, Nomura M et al. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Ann Surg Oncol 2006; 13: 836-842.
9. Talamonti MS, Kim SP, Yao KA et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery 2003; 134: 720-727; discussion 727-9.
10. Iasonos A, Schrag D, Raj GV et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008; 26: 1364-1370.
11. Han DS, Suh YS, Kong SH et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol 2012; 30: 3834-3840.
12. Kattan MW, Karpeh MS, Mazumdar M et al. Postoperative nomogram for diseasespecific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003; 21: 3647-3650.
13. Kim JH, Kim HS, Seo WY et al. External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer. Ann Oncol 2012; 23: 361-367.
14. Kim DH, Kim SM, Hyun JK et al. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods. Ann Surg Oncol 2013; 20: 2317-2327.
15. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 13 ed. Tokyo: Kandera 1999.
16. Akazawa K, Nakamura T, Palesch Y. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples. Stat Med 1997; 16: 583-597.
17. Harrell FE, Jr, CaliffRM, Pryor DB et al. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-2546.
18. Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle. Budapest: Hungary Akademiai Kiado 1973.
19. Nakajima T, Kinoshita T, Nashimoto A et al. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg 2007; 94: 1468-1476.
20. Sakuramoto S, Sasako M, Yamaguchi T et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820.
21. Bang YJ, Kim YW, Yang HK et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379: 315-321.